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ABSTRACT Intracellular calcium ion ([Ca2+]i) transients were measured in single rat ventricular myocytes with the fluorescent indicator
furaptra. Cells were voltage clamped with a single patch electrode containing the K+ salt of furaptra and fluorescence at 500 nm was
measured during illumination with 350 and 370 nm light. Depolarizing voltage-clamp pulses elicited [Ca2+]-dependent fluorescent
transients in 30 of 33 cells tested. The peak change in [Ca]2+] elicited by 50-ms depolarizations from -70 to +10 mV was 1.52 ± 0.25
,qM (mean ± SEM, n = 7). The size of the [Ca]2+] transient increased in response to 10 ztM isoproterenol, prolongation of the
depolarization, and increasing pipette [Na+]. Because furaptra is sensitive to Ca2+ and Mg2+, changes in [Mg2+]i during the [Ca]2+]
transient could not be measured. Instead, a single-compartment model was developed to simulate changes in [Mg2+] during [Ca2+]
transients. The simulations predicted that a 2 ,uM [Ca2+] transient was accompanied by a slow increase in [Mg2+] (14-29 JAM), which
became larger as basal [Mg2+] increased (0.5-2.0 mM). The [Mg2+] transient reached a peak - 1 s after the peak of the [Ca2+]
transient with the slow changes in [Mg2+] dominated by competition at the Ca2+/Mg2+ sites of Troponin. These changes in [Mg2+],
however, were so small and slow that they were unlikely to affect the furaptra fluorescence signal at the peak of the [Ca2+ ]i transient. The
[Ca]2+] transient reported by furaptra appears to be larger than that reported by other Ca2+ indicators; however, we conclude this larger
transient is at least as accurate as [Ca]2+j transients reported by the other indicators.
INTRODUCTION
The central role of intracellular calcium ion concentra-
tion ([Ca> ]i) in controlling heart contractile function
has motivated the development of a variety of experi-
mental methodologies to measure [Ca> ]i in cardiac
myocytes. The most versatile of these methods uses
Ca> -sensitive optical indicators, such as aequorin ( 1),
which allow rapid changes in [Ca> ]i to be observed. The
introduction of the ratiometric Ca> indicators, fura-2
and indo-1 (2), has led to a dramatic improvement in
the ability to measure changes in [Ca>2]i because, unlike
aequorin, these fluorescent indicators form a 1:1 com-
plex with Ca>2 and have Ca21 -binding affinities close to
physiological [Ca2 ]i. More recently several nonratio-
metric Ca>2 indicators have also been introduced.
Concerns have been raised about quantitation of
[Ca2 ]i in heart muscle with some of these new Ca>2
indicators because their Ca21 -binding and optical prop-
erties appear to be different in the intracellular environ-
ment than in in vitro conditions. A sizable fraction of
fura-2 and indo- 1 is bound in the intracellular environ-
ment (3-5), and this binding appears to affect the Ca>2-
indicator properties ofthese compounds (3, 5). Another
concern is that the reaction kinetics of fura-2 are too
slow to accurately track rapid changes in [Ca2+]i that
occur during the stimulated [Ca2 ]i transient, as has
been reported in skeletal muscle fibers (6, 7). Finally, in
the presence of spatial gradients of [Ca>2]i (8, 9), it is
not clear that fura-2 gives an accurate measure of spatial
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mean [Ca> ]i because of possible saturation ofthe indi-
cator in the regions of high [Ca">]i (10).
The potential complexities in relating changes in fura-
2 fluorescence to [Ca2+] point out the advantages in hav-
ing a variety ofCa>2 indicators with different Ca2+-bind-
ing properties to check the accuracy of Ca 2+ measure-
ments made in cardiac cells with more commonly used
indicators such as fura-2 and indo- 1. Recently, Konishi
et al. ( 11 ) demonstrated that furaptra, a fluorescent indi-
cator originally designed to measure Mg2> (12), can be
used to measure the rapid changes in [Ca2+] that occur
in skeletal muscle fibers. Preliminary data also suggested
that Ca2+-dependent changes in furaptra fluorescence
could be measured in cardiac myocytes; however, these
changes were unreliable due to movement artifacts that
obscured Ca2 -dependent changes in fluorescence ( 13).
In this report, we demonstrate that furaptra can reli-
ably be used to measure the amplitude of the [Ca>2]i
transient in cardiac myocytes. We present a method to
calibrate Ca2+-dependent changes in furaptra fluores-
cence and estimate the degree to which Mg2+-dependent
changes in fluorescence complicate measurement of
[Ca2+ ].
Some of the data have been previously published in
abstract form ( 14, 15).
MATERIALS AND METHODS
General
The experimental techniques used in this study are modifications of
previously published methods ( 16). Single ventricular myocytes were
enzymatically isolated from rat hearts by a modification ofthe method
of Mitra and Morad ( 17 ). After enzymatic digestion and dispersion,
cells were stored in a 0.2 mM CaC12-containing Tyrode's solution at
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room temperature or at 6°C until used. Cells were placed in an experi-
mental chamber ( 18) on the stage ofan inverted microscope (Diaphot,
Nikon Inc. Instrument Division, Garden City, NY) and superfused
with a 2 mM CaC12 Tyrode's solution. Cells were voltage clamped via a
single electrode technique (19) with patch pipettes of 1-2 MQ resis-
tance filled with a salt solution containing 0.3-1.0 mM furaptra or 50
1gM fura-2 (both as the K+ salt). After formation of a GQ seal, zero
current and background fluorescence were measured. The membrane
patch under the pipette was then ruptured to establish a whole cell
voltage clamp and allow indicator diffusion into the myocyte. Fluores-
cence measurements were carried out under conditions where dye
loading was near steady-state levels.
Solutions and materials
Myocytes were superfused with a Tyrode's solution containing (mM)
140 NaCl, 4 KCI, 1 MgCl2, 2 CaC12, 10 glucose and 10 HEPES
(N-[2-hydroxyethyl]piperazine-N'- [2-ethanesulfonic acid]), pH 7.4.
All experiments were performed at room temperature. The internal
electrode solution contained (mM): 70 cesium glutamate, 50 KCI, 15
CsCl, 1 MgCl2, 2.5 ATP (K+ salt), 0.01-0.07 EGTA, and 25 PIPES,
pH 7.2.
All chemicals were reagent grade. Isoproterenol bitartrate was pur-
chased from Sigma Chemical Co. (St. Louis, MO). The tetrapotassium
salt offuraptra (Mag-fura-2, Lot 9A) and pentapotassium salt offura-2
were purchased from Molecular Probes Inc. (Eugene, OR).
Equipment for fluorescence
measurement
Light from a xenon arc (PTI Inc., South Brunswick, NJ) was collected
and partially collimated before passing through narrow-band interfer-
ence filters (10 nm FWHM). The excitation wavelength was selected
by moving two filters into the light path between consecutive depolar-
izations under the control ofa stepper motor filter changer. The filtered
light was then focused onto one end of a liquid light guide. The other
end of the light guide was placed in the epifluorescence port of the
microscope so that the image of the light guide formed by a divergent
lens was at the back image plane of a high N.A. oil immersion objec-
tive, which focused the ultraviolet light onto the cell. Incident light was
limited to the area ofthe cell with an adjustable field stop. An electronic
shutter (Vincent Electronics, Rochester, NY) also limited the exposure
ofthe cell to light for 1.0-1.5 s periods around each depolarization. The
intensity of the excitation light was attenuated with neutral density
filters until the half-time for bleaching ofthe indicator was ~-90 s. Light
from the Kohler illuminator of the microscope was used throughout
the experiments to view the cell with a CCD camera (NEC Corp.,
Mountain View, CA) but was limited to wavelengths longer than 750
nm with a longpass interference filter.
Fluorescent light at 500 nm (40 nm FWHM) was measured with a
photomultiplier tube (Thorn EMI, Rockaway, NJ) after separation of
light with wavelengths longer than 700 nm by dichroic mirrors. A field
stop limited the view ofthe photomultiplier to the area ofthe myocyte.
Membrane potential, current, and fluorescence were recorded on
videotape (Instrutech VR-100, Elmont, NY). For analysis, recorded
data was filtered at 500 Hz with an eight-pole Bessel filter and digitized
at I kHz (DT2801A, Data Translation, Inc, Marlboro, MA) using
commercially available software (A2D+; Medical Systems, Greenvale,
NY). Fluorescence data presented in the figures are the signal average
ofconsecutive traces from six to eight depolarizations at each illumina-
tion wavelength.
Calibration
In vitro calibrations of furaptra were carried out on the experimental
apparatus with a glass capillary 100 ,lm in diameter. The calibration
solution contained 140mM KCI, 1 ,uM furaptra (K+ salt), and 10 mM
PIPES (piperazine-N,N'-bis [ 2-ethanesulfonic acid]), pH 7.2. For cali-
bration ofcalcium-dependent changes in fluorescence, 5 mM HEDTA
(N-hydroxyethylethylenediaminetriacetic acid) and various amounts
of CaCl2 were added to set free Ca2+ concentrations. Magnesium-de-
pendent fluorescence changes were determined in the presence of 0.2
mM K2EGTA [ethylene glycol-bis(,B-aminoethyl ether)N,NN,N'-
tetraacetic acid] to remove contaminant Ca2 . Free magnesium con-
centration was set by dilution of a I M MgCl2 stock solution without
additional buffers. Free ion concentrations were calculated with a com-
puter program, MaxChelator, version 4.61 (written by Chris Patton,
Hopkins Marine Station, Pacific Grove, CA), that used the equations
from Fabiato and Fabiato (20) and dissociation constants determined
by Harrison and Bers (21 ) and Martell and Smith (22).
RESULTS
Furaptra has been previously reported to have fluores-
cent properties very similar to fura-2, with a significant
blue shift in the excitation spectrum on metal binding,
and an isosbestic point of 347 nm (12). Fig. 1 A shows
furaptra fluorescence at different [Ca2+] observed dur-
ing an in vitro calibration on the experimental apparatus.
Excitation with 340 or 350 nm light showed small Ca2-
dependent changes in fluorescence in opposite direc-
tions, consistent with the isosbestic point being between
these two excitation wavelengths. Konishi et al. (11)
showed that the isosbestic point for furaptra is similar for
Mg-2+ and Ca2+ -dependent changes in fluorescence. Flu-
orescence records in the remainder of the paper are pre-
sented under the assumption that records during 350 nm
illumination represent fluorescence at the isosbestic
point. Excitation at 370 nm showed a large Ca2+-depen-
dent decrease in fluorescence. At saturating Ca,2+ fluo-
rescence intensity was -10% of that observed in zero
Ca2+ solution, consistent with Konishi et al. (11), who
showed that the extinction coefficient (at 420 nm) is
greatly decreased upon complexation with Ca2. To de-
termine the KD for Ca2, a 1: 1 binding curve was fitted
by a nonlinear least-squares routine to the fluorescence
data measured with 370 nm excitation light. From the
curve (Fig. 1 A), KD for Ca2+ was calculated to be 58 uM.
In a total of three calibrations, average KD(Ca) equaled
47 ± 6,uM (mean ± SEM), very similar to the published
values (Raju et al. (12), 53 ,M at 37°C; Konishi et al.
(11), 44 MM at 16°C).
Fig. 1 B shows the Mg2+-dependent changes in furap-
tra fluorescence during excitation with 370 nm light.
The Ca 2+ concentration was maintained at low levels
with 0.2 mM EGTA and Mg2+ concentration was varied
by adding MgCl2 to a HEPES-buffered solution at pH
7.2. A KD of 3.6 mM (23°C) was calculated by the same
method described in part A of the figure (solid curve).
This fitted value ofKD( Mg) is intermediate between 1.5
mM at 37°C, reported by Raju et al. (12), and 5.3 mM
at 16°C, reported by Konishi et al. (11).
Furaptra fluorescence transients
Given the low affinity of furaptra for Ca>2, we expected
that Ca2+-dependent changes in fluorescence would be
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FIGURE I Ion dependence of furaptra fluorescence. Calibrations were
carried out in the experimental chamber using 100 Am inside diameter
glass capillaries that contained (mM) 140 KCI, 0.001 furaptra (K+
salt), and 1O PIPES, pH 7.2 at room temperature. (A) Ca2+ dependence
of fluorescence. 5 mM HEDTA and various amounts of CaCl2 were
used to set the [Ca2"]. The capillary was illuminated with 340 nm
(circles), 350 nm (squares), or 370 nm light (triangles) and fluores-
cence measured at 500 nm. The solid lines through the data were deter-
mined by nonlinear least-squares fit assuming l-to-l binding. (B)
Mg2+ dependence offluorescence measured with 370 nm illumination.
Various amounts of MgC12 were added with 0.2 K2EGTA to the basic
solution to yield the desired [Mg2+] . The solid line was least-squares-fit
as in A.
quite small, 0.5-2.0%, because the peak change in
[Ca2 ]i during a stimulated transient has been reported
to be 250-1,000 nM ( 16, 23). We also anticipated that
movement artifacts would pose a serious problem, as has
been reported by Cleeman and Morad ( 13). For these
reasons, attempts were made to improve the signal-to-
noise ratio of the fluorescence signal by 1) use of high
indicator concentrations (0.3 or 1.0 mM) in the patch
electrode solution, 2) collection of the fluorescence sig-
nal from almost the entire area of the cell, and 3) signal
averaging six to eight fluorescence records. Given these
conditions, fluorescent transients could reliably be elic-
ited by voltage-clamp depolarizations with almost every
cell [30 of 33 cells examined in this study and Berlin and
Konishi (15)]. The three cells that did not show any
[Ca2 ]i-dependent fluorescence transients also showed
little or no contraction in response to voltage-clamp de-
polarizations. In voltage-clamped myocytes loaded with
fura-2, we observe a similar percentage of cells in which
[Ca2 ]i transients cannot be elicited. Thus, we find that
furaptra can be used reliably to measure stimulated
[Ca2 ]i transients.
Figs. 2 and 3 illustrate furaptra fluorescence transients
and their conversion to changes in [Ca2 ]i. In Fig. 2 A,
the cell was depolarized from -70 to + 10 mV for 500 ms
(top panel) at 0.2 Hz. When fluorescence was measured
during excitation with 350 nm light (secondpanel), the
voltage clamp pulse produced a fluorescence transient
that increased slowly, remained elevated for the duration
ofthe depolarization, and returned to resting levels after
repolarization. From Fig. 1, it is clear that this change in
fluorescence is in the opposite direction of those antici-
pated from an increase in [Ca>2 ]i. It is also unlikely that
this change in fluorescence reflects a change in intracel-
lular [Mg>2] (see Fig. 6); however, the change does
roughly parallel the time course expected for cell contrac-
tion. The interpretation that the signal during 350 nm
illumination reflects a movement artifact is supported
by the finding that depolarizations of 50 ms duration
produce a fluorescent transient of shorter duration. This
change is consistent with the absence of a tonic compo-
nent of cell contraction with a 50-ms depolarization
which could be present with a 500-ms depolarization.
Thus, the changes in fluorescence measured with 350
nm illumination, a wavelength close to the isosbestic
point, most likely reflect cell movement.
The third panel of Fig. 2 A shows the fluorescence
transient recorded during illumination with 370 nm
light. A rapid decrease in furaptra fluorescence is fol-
lowed by a slower increase in fluorescence intensity that
lasted the duration of the depolarization. The rapid de-
crease in fluorescence intensity is consistent with an in-
crease in [Ca2+]i; however, as above, the prolonged in-
crease in fluorescence is in the opposite direction of ex-
pected for either an increase in Ca2+ or Mg2>.
Artifacts due to cell movement can, in principle, be
removed by taking the ratio of fluorescence intensities at
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FIGURE 3 Calibration of furaptra fluorescence. The top panel shows
the voltage-clamp depolarization. The bottom panel shows the
corrected fluorescence transient resulting from signal-averaging fluores-
cence records from eight depolarizations with 350 and 370 nm illumi-
nation. The conversion to A[Ca2+]j, as determined by Eq. 4, is shown
on the righthand scale.
two illumination wavelengths (2). The fluorescence ra-
tio signal of furaptra (bottom panel of Fig. 2 A) rises
rapidly after membrane depolarization and reaches a
peak within 30-35 ms. The signal then decreases back
toward resting levels. The waveform ofthe ratio signal is
consistent with anticipated changes in [Ca21]i during a
transient. Conversion of the fluorescence ratio into
[Ca2+]j, however, is complicated because the ratio is de-
pendent on the degree of Ca2' and Mg2' binding to the
indicator and the amount of Mg2' bound to furaptra is
likely to be much larger than the amount ofbound Ca2 .
To overcome this problem, we have adopted an alternate
method of calibration to correct for movement artifacts
in the fluorescent signal measured during illumination
with 370 nm light.
The alternative calibration method is summarized in
Eqs. 1-4 below. To correct the 370 nm fluorescence sig-
nal for movement artifacts, it is assumed that changes in
fluorescence at the isosbestic point (350 nm illumina-
tion) appear in an identical proportion in fluorescence
signals measured with other illumination wavelengths.
FlCOrr(0t = F1370( t) * M( t) F1350(ret)MM -F1350(ret
Flcorr(t) = cf * [D]t + vb [DCa]t = Ef * [D]t
zAfD(t) Fl (rest)- Fl Fli = Flcorr(rest).
200 ms
FIGURE 2 Calibration of fluorescence signals. (A) Removal of move-
ment artifact from fluorescence signals. The top panel shows the volt-
age clamp pulse which was delivered every 5 s. The second and third
panels show the 500-nm fluorescence records (average ofsix depolariza-
tions each) acquired during illumination at 350 and 370 nm, respec-
tively, and displayed in arbitrary intensity units. The fourth panel
shows the corrected fluorescence signal calculated as described in the
text using Eq. 1. The bottom panel shows the ratio of fluorescence
intensities measured during 350 and 370 nm illumination. (B) Com-
(1)
(2)
- . (3)
Cf
Movement-corrected fluorescence (Fl40,) is calculated
by multiplying the fluorescence signal during 370 nm
illumination [F1370(t)] by M(t), the ratio offluorescence
recorded before the depolarization [F1350(rest)] and at
time, t [F1350(t)], during 350 nm illumination (Eq. 1).
Because changes in fluorescence during 350 nm illumina-
parison of the corrected and uncorrected fluorescence signal. The top
panel shows the voltage-clamp depolarization. The bottom panel shows
superimposed fluorescence records expressed in arbitrary intensity
units. No scaling or offsets have been added to either record.
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tion reflect cell movement, changes in M(t) are inversely
proportional to the size of the movement artifact. Florr,
shown in the fourth panel of Fig. 2 A, should reflect
ion-dependent changes in fluorescence free of move-
ment artifacts. Fl4,r is also the sum of the fluorescence
signals from the Ca2+-free (D) and Ca2 -bound (DCa)
forms of furaptra. However, a) the ratio of the fluores-
cence coefficients for the bound and free form of furap-
tra (Eb!/ Ef) determined during in vitro calibrations is
small and b) [DCa] / [D] is very small, so that changes in
the fluorescence signal arise almost exclusively from the
changes in Ca2 -free indicator concentration (Eq. 2).
Therefore, a fractional change in fluorescence will corre-
spond directly to a change in the fraction of Ca2 -free
indicator.
Eq. 3 relates changes in fluorescence to changes in the
fraction ofCa2 -free furaptra [ LfD(t) ]. The Ca2 -sensi-
tive component of the fluorescence signal [F41cr.(t) -
Fli] at time t is divided by the Ca2 -sensitive component
recorded before the voltage-clamp depolarization
[Flc40( rest) - Fli ], where the value of Fli is the expected
fluorescence signal in saturating [Ca2 ]i, i.e., the Ca>2-
insensitive fluorescence. Fli is calculated as the fluores-
cence before the depolarization [Flcorr(rest)] times the
ratio of the fluorescence coefficients for the Ca2 -bound
and Ca2 -free forms of furaptra.
Two underlying assumptions are implicit in the calcu-
lation of AfD(t). First, Fl4,(rest) is assumed to be the
level of fluorescence with no Ca>2 binding. If resting
[Ca2 ]i is 100 nM, then the Ca2 -bound fraction of the
indicator is only 0.5%, so that this assumption leads to
only very small errors in calibration. Second, [Mg2+]
must not significantly change during the [Ca2+]i tran-
sient. This latter assumption is examined in Fig. 6.
Because AfD( t) arises from Ca2+-free furaptra,
1 - AfD( t) equals the change in the fraction of furaptra
bound to Ca>2 [AfDc,(t)], which is directly propor-
tional to the change in [Ca2+](zMCa2+]i), as shown in
Eq. 4:
2[Ca2 ]i= KD [1 AfD(t)] =KD.Af(t).
This equation is essentially the same as Eq. 4 in Konishi
et al. ( 11 ) but simplified because the fractional binding
of furaptra with Ca>2 in the present experiments is small
(usually <5%). KD was determined in vitro as in Fig. 1
and adjusted for competition with Mg2+. Intracellular
Mg 2+ concentration ( [Mg2+ ]i)was not studied systemati-
cally during these experiments and was assumed to be
0.5 mM. This value is similar to that reported in several
recent studies using furaptra (24), ion-selective elec-
trodes (25), and '9F-NMR (24). The adjusted KD for
Ca2+ is 54 ,uM.
The movement artifact in the fluorescence recorded
during illumination with 370 nm light can often be as
large or larger than the Ca2+-dependent change in fluo-
rescence (cf. thirdpanel of Fig. 2 A). Ratiometric meth-
ods (including calculation of FIc.r) are designed to re-
move the contribution of cell movement (or any change
in effective pathlength) from the calibration process.
Nonetheless, large movement artifacts may be difficult
to completely remove, particularly with the experimen-
tal procedure used here, where the illumination wave-
length is alternated with consecutive depolarizations.
For this reason, we have more closely examined the po-
tential for movement artifact to contribute to F4cOIT used
in the calibration. Fig. 2 B shows the raw fluorescence
signal recorded during 370 nm illumination superim-
posed on the Flco,4 signal. The initial change in fluores-
cence coincides closely for both signals. Correcting for
the movement artifact delays the peak change in fluores-
cence of Flco, from 18 to 32 ms after the beginning ofthe
depolarization and increases the amplitude from a 1.8 to
a 2.0%. Thus, most ofthe rapid rising phase ofthe fluores-
cence transient occurs before onset ofthe movement ar-
tifact. Because the peak Ca2 -dependent change in fluo-
rescence occurs at a time when cell movement is only
very slight, movement artifact correction alters the esti-
mation ofpeak changes in [Ca2+]i by 10%. On the other
hand, the falling phase of the [Ca2 ]i transient and the
tonic elevation of [Ca2 ]i occur during cell contraction.
Thus, in later phases of the [Ca>2]i transient recorded
with furaptra, we have no independent verification that
movement artifacts do not significantly alter the Fl4orr
signal.
The above calibration method is used in Fig. 3 to con-
vert Flcorr to A[Ca2+]i. The cell was depolarized from
-70 to + 10 mV for 50 ms every 5 s and the signal-aver-
aged fluorescence transient is shown as AfDca. The peak
change in fluorescence is 5.2%, which converts into a
peak A[Ca2+]i of 2.8 ,uM. Although this was one of the
larger [Ca2+]i transients observed, on average, the peak
v[Ca2+ ]i was 1.52 ± 0.25 ,M (mean ± SEM, n = 7), and
the average time to peak change in [Ca2+]i was 36
3 ms.
To determine if the furaptra fluorescence transient
(AfDc,) was consistent with the [Ca2+]i transient ex-
pected for cardiac myocytes, we tested the effect of
various experimental interventions on the size ofthe flu-
orescence transient. Fig. 4 A shows an experiment that
examined the effect of isoproterenol, a 3-adrenergic ago-
nist expected to increase the size ofthe [Ca>2]i transient
in cardiac muscle ( 1). Before drug addition, the peak
change in fluorescence in response to 50-ms depolariza-
tions to +10 mV every 5 s was 1.6%, or a 0.86-,uM in-
crease in [Ca>2 ]i . After the addition of 10 ,uM isoproter-
enol to the superfusion solution, the fluorescence tran-
sient showed a peak change of 4.6% or a 2.48-uM
increase in [Ca>2]j. Thus, in this cell, isoproterenol pro-
duced a 160% increase in the size ofthe [Ca2+ ]i transient
compared with control. In six cells, 10 ,uM isoproterenol
led to an 84 ± 28% increase in the size ofthe fluorescence
transient.
A second experimental maneuver was to increase the
duration ofthe depolarizing voltage clamp pulse from 50
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FIGURE 4 Effect of various interventions on the size of the furaptra
fluorescence transient. (A ) Isoproterenol. The top panel shows the volt-
age-clamp pulse used in this experiment. The bottom panel shows two
superimposed corrected fluorescence transients recorded during super-
fusion with 0 and 10 AM isoproterenol. (B) Depolarization duration.
Superimposed corrected fluorescence transients for 50- and 500-ms-
long depolarizations from -70 to +10 mV delivered every 5 s. The
transient resulting from the 500-ms-long voltage-clamp pulse has a
higher peak change and a slower rate ofrecovery offluorescence toward
resting levels.
to 500 ms. The result of such an experiment is shown in
Fig. 4 B, where fluorescence transients elicited by the
two different depolarizations have been superimposed.
The fluorescence transient arising from the 500-ms depo-
larization shows a larger peak amplitude. Increasing
clamp pulse duration has been previously reported to
increase the size of the [Ca>]i transient in myocytes
loaded with fura-2 (13, 26) and indo- 1 (27).
The third maneuver was to increase the NaCl concen-
tration in the patch pipette solution from 0 to 8 mM.
Maneuvers that increase intracellular [Na+] have been
reported to increase the size ofthe [Ca> ]i transient (28)
and the strength of contraction (29). In the four cells
tested, voltage-clamp pulses of 50 ms duration from -70
to + 10 mV delivered at 0.2 Hz led to an average AfDc, of
3.7 ± 0.4%, which corresponds to a peak A[Ca2+ji of 2.0
,uM. This represents an increase of 30% over the average
size of the [Ca2+]i transients observed with pipette solu-
tions containing 0 mM NaCl. In summary, during three
separate experimental maneuvers, changes in the furap-
tra fluorescence transient were consistent with antici-
pated changes in the [Ca>2]i transient. Thus, we con-
clude that the furaptra transient is a measure of the
change in the size of the [Ca 2+ ]i transient.
Effect of intracellular [Mg2+ ] on the
size of the furaptra fluorescence
transient
Furaptra was originally designed as a Mg2+ indicator
( 12). Thus, a pertinent question is whether changes in
[Mg2+ ]i contribute to the furaptra fluorescence transient
and, thereby, confound the calibration of fluorescence
changes in terms of[Ca2+]. The changes in [Mg2+]i dur-
ing [Ca2+]i transients have not been directly examined
in cardiac muscle. This is due largely to the fact that
Mg2+ indicators, including furaptra, are also Ca2+-sensi-
tive, so that during rapid changes in [Ca2+]i, it is not
possible to unequivocally determine [Mg2+]i. There is
reason to believe, however, that [Mg2+]i does change, at
least somewhat, during the [Ca2+]i transient because
there are many buffer species in the cell where Ca2+ and
Mg2+ can compete (see Table 1). These buffer species
include the Ca2+/Mg2+ sites on troponin and myosin as
well as sites on ATP, phosphocreatine, and calmodulin.
As shown in Table 1, the potential sites in the cell where
Ca2+ can compete with Mg2+ are quite numerous.
Our inability to experimentally examine [Mg2+]i led
us to develop a computer model to estimate what
changes in [Mg2+]i accompany changes in [Ca2+]j. The
goal of these simulations was to estimate the extent to
which changes in [Mg2+]i contribute to the amplitude of
the furaptra fluorescence transient so that any error in
the calculation of change in [Ca2+]i might be assessed.
The model assumed the cytosolic space accessible to fur-
aptra is represented by a single compartment containing
furaptra and buffer species (Fig. 5). Ca2+ and Mg2+ bind-
ing to the buffer species (B) and furaptra (D) were calcu-
lated by simultaneously solving the following equations
for each buffer using an Euler's numerical integration
routine (30):
dBC(t) = B(t) - Ca(t) k-ca- BCa(t) * kca
dt
(5)
dM(t) = B(t)*Mg(t) *kfMg-BMg(t)*kr,Mg. (6)
dt
Forward rate constants for Ca> (kf,c) and Mg> (kf,mg)
were assumed to be 1.25 e + 08 M-l s-I and 3.33 e + 04
1336 Biophysical Journal Volume 641 336 Biophysical Journal Volume 64 April 1993
TABLE 1 Ca2 + /Mg2 + Buffers
Species Concentration KD kf kr
,umollliter M M-' s-' s-'
Furaptra
Ca 300 4.7e-05 1.25eO8 5,875
Mg 3.6e-03 3.33eO4 120
Troponin
Ca 2 x 70 3.3e-09 1.0eO8 0.33
Mg 3.3e-05 3.33eO4 1.11
Myosin
Ca 2 x 70 3.33e-08 1.37eO7 0.46
Mg 3.64e-04 1.57eO4 0.057
CaMod 1
Ca 6 1.88e-06 1.25eO8 235
Mg 1.96e-03 3.33eO4 64.7
CaMod 2
Ca 6 1.84e-06 1.25eO8 230
Mg 2.92e-03 3.33eO4 96.4
CaMod 3
Ca 6 7.49e-06 1.25eO8 938
Mg 1.25e-03 3.33eO4 51.3
CaMod 4
Ca 6 6.14e-05 1.25eO8 7,675
Mg 6.14e-03 3.33eO4 203
ATP
Ca 3,000 2.0e-04 1.25eO8 2.5eO4
Mg 9.0e-05 3.33eO4 3.0
P-Creatine
Ca 12,000 7.1e-02 1.25eO8 8.9eO6
Mg 5.0e-02 3.33eO4 1,670
The values for intrinsic buffer concentrations are expressed as micro-
mole per liter accessible cell water and equilibrium dissociation con-
stants (KD) are taken from Fabiato (33). Diffusion-limited on-rate con-
stants (kf) are taken from Robertson et al. (32) to calculate off-rate
constants (kr). The concentration of furaptra is assumed to be equal to
the electrode concentration and off-rate constants are calculated assum-
ing diffusion-limited on-rate constants. The two sites on myosin and
troponin C are assumed to behave identically and the four sites on
calmodulin (CaMod1-4) are assumed to behave independently. ATP
and phosphocreatine (P-Creatine) are included without accounting for
the low cellular concentrations of dephosphorylated metabolites that
are present in the normal intracellular environment.
M-1 s-i, respectively. Reverse rate constants (kr,a
kr,Mg) were taken from Holroyde et al. (31 ) and Robert-
son et al. (32) or calculated from equilibrium binding
constants (33). The concentration of the buffer species,
taken from Fabiato (33), equaled the sum of the Ca2 -
bound (BCa), Mg2+-bound (BMg), and unbound
forms (B) of the buffer, and the concentration of furap-
tra was assumed to equal the pipette concentration. The
step size (At) was reduced until no change in the numeri-
cal solution was observed. When necessary Ca(t + At)
was determined by linearly interpolating between consec-
utive data points.
A sample [Ca2+] transient used as the driving function
in these calculations is shown in Fig. 6 A. The [Ca2+]
transient was measured in a myocyte loaded with fura-2
because this indicator has a very low affinity for Mg2+
(2), so that the timecourse of the transient reflects only
changes in [Ca2+]. However, the experimental condi-
tions and the voltage clamp protocol were the same as
those used in Fig. 3. The [Ca2+] transient was obtained
from the fura-2 fluorescence signal as described previ-
ously (23) except for a scaling factor that left resting
[Ca2+] unchanged at 35 nM but increased peak [Ca>2]
to 2.0 ,uM, similar to the size of the [Ca2+]i transients
determined with furaptra.
Simulations were run at two initial [Mg2+], 0.5 mM
(Fig. 6, left panels) and 2.0 mM (right panels). Total
intracellular Mg2+ was the sum of Mg2> bound to the
intracellular buffers and [Mg2>]. The value of total
Mg2+, calculated at t = 0 by assuming [Mg2>] and
[Ca2+] were in equilibrium with all buffers, was held
constant throughout the calculation, i.e., there is no net
entry or efflux of Mg2+ from the cytosol (see Discus-
sion). Buffers with slow binding rate constants, such as
myosin and troponin (see Table 1 ), necessitated that the
simulation be run several times before consecutive
[Ca>2] transients produced repeatable changes in Ca2+
and Mg>2 binding. Fig. 6, B-F, therefore, show the time
course ofbinding only during the last [Ca2+] transient of
the entire simulation.
Fig. 6, B and C, shows the calculated changes in Mg2+
binding to calmodulin and Ca2+/Mg2+ sites oftroponin,
respectively. Calmodulin is shown as an example of a
fast buffer, in rapid equilibrium throughout most of the
[Ca2+]i transient, so that the time course of changes in
Mg2+ binding closely approximate changes in [Ca>2].
The fast buffers also include ATP, phosphocreatine, and
furaptra. At the peak of the [Ca>2+] transient only a very
small amount of Mg2+ is displaced from calmodulin (a
total of 1.2 ,uM with 0.5 mM [Mg2+] and 2.3 ,uM with
2.0 mM [Mg2+]) because calmodulin is predominantly
in the metal-free state at resting [Ca2+]. Thus, the rapid
increase in [Ca2+] results in Ca2+ binding largely to the
D
Ca
kr,Ca
Mg
kf,Mg
krMg
n = 1, 2,3
FIGURE 5 Model for Ca2" and Mg2" competition within a myocyte.
Furaptra, D, and cellular buffers, B (see Table 1), can bind either Ca2"
or Mg2", assuming 1-to- 1 binding stoichiometry. Buffer species with
multiple binding sites are assumed to show independence between
sites. The myoplasmic space accessible to Mg2' and Ca2+ is assumed to
consist of a single, identical compartment with instantaneous mixing.
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FIGURE 6 Results ofsimulations examining how Ca2" and Mg2" com-
petition affects furaptra fluorescence. The lefthand panels are from a
simulation performed with an initial [Mg2+] of 0.5 mM and the right-
handpanels are from an identical simulation run with 2.0mM [Mg2+].
For some panels, the values on the vertical axis of the left- and right-
hand panels are different, but the increment along the axis is the same.
All records displayed are from the last ofthe three repeats ofthe simula-
tion calculations needed to achieve steady-state conditions in the
model. (A) The [Ca2+] transient used as a driving function for the
simulation. The [Ca2+] transient is scaled so that peak [Ca2+] is 2.0 ,uM
and resting [Ca2+] is 35 nM. The transient was recorded from a cell
voltage clamped with the electrode solution (see Methods) containing
50 ,M fura-2 (K+-salt) and depolarized from -70 to +10 mV for 50
ms at 0.2 Hz. (B) Mg2+ binding to calmodulin. The sum of Mg2+
binding to all four sites of calmodulin is displayed. Total binding site
concentration is 24 ,M/liter cell myoplasm. (C) Mg2' binding to tro-
ponin. The sum of Mg2+ binding to the 2 Ca2+/Mg2+ binding sites of
troponin is displayed. The total number ofbinding sites is 140 JuM/liter
cell myoplasm. (D) [Mg2+] transient. (E) Ca2+ binding and Mg2+
binding to furaptra. (F) Predicted furaptra fluorescence. The solid lines
show the change in furaptra fluorescence predicted from the changes in
[MgFuraptra] and [CaFuraptra] in E, assuming total furaptra is 300
MM. Fluorescence was calculated using Eq. 7 and the molar fluores-
cence coefficients from Fig. 1 (see text). The dashed lines were calcu-
lated after repeating the simulations except that [Mg2+] was held con-
stant at 0.51 (left) and 2.02 mM (right).
unbound calmodulin. In general, increasing the concen-
tration of fast Mg> binding sites improved the buffering
of free Mg> and decreased the amplitude ofthe [Mg"]
transient without significantly altering its time course.
Fast Mg> buffers do not appear to be major sites for
competition between Mg> and Ca". Fig. 6 C shows the
time course of changes in Mg> binding to the two
Mg2+/Ca2+ sites of troponin (both sites are assumed to
have identical rate constants). Because ofthe slow Mg2+
off-rates, these sites respond slowly to changes in [Ca>2],
i.e., changes in Mg2+ binding lag far behind the [Ca2+]
transient. The large amount of Mg>2 displaced from tro-
ponin (26 ,M with 0.5 mM [Mg2>] and 29 ,uM with 2.0
mM [Mg2+]) occurs because this buffer is almost com-
pletely bound with either Ca>2 or Mg2+. Additional
Ca2+ binding, therefore, occurs only after displacement
ofbound Mg2+. Thus, most competition between Mg2+
and Ca 2+ occurs at sites on slow buffers such as troponin
and myosin.
The domination of competition between Mg2+ and
Ca2+ by slow buffers suggests that displacement of
bound Mg2> from these buffers will dominate the change
in [Mg2+ ] during the [Ca>2+] transient. In fact, our calcu-
lations predict that the peak change in [Mg2+] occurs
>1 s after the beginning of the [Ca>2+] transient (Fig. 6
D). The size of the change in [Mg2+] is small (14 ,uM
with 0.5 mM [Mg2+ ] and 29 MuM with 2.0mM [Mg2+]),
principally because ATP binds with a significant fraction
ofthe displaced Mg2+ . At the time ofthe peak change in
[Ca2+], [Mg2+] has increased only slightly. Thus,
changes in [Mg2+ ]i are predicted to be small, even in
response to a large [Ca2+]i transient.
Fig. 6 E shows the changes in Ca2+and Mg2+ binding
to furaptra. Because furaptra is a fast buffer for Ca2+,
and likely a fast buffer of Mg2+, it is not surprising that
the simulation predicts that divalent cation binding to
the indicator closely follows the time course of the
[Ca>2+] transient and the slow changes in [Mg2+] . At the
time ofthe peak ofthe [Ca2+] transient, Mg2+ binding to
furaptra decreases rather than following the initial rise in
[Mg2+], because the competition between Ca2+ and
Mg2+ more than offsets the increase in Mg2+ binding
that would be expected from the slight rise in [Mg2+].
The amount of Ca2+ binding to furaptra decreases with
2.0mM [Mg2+], consistent with an increase in the appar-
ent KD for Ca>2 at higher Mg2+ concentrations.
The amount ofCa2+and Mg2+ binding to the indica-
tor was used to calculate predicted furaptra fluorescence
transients during 370 nm illumination with the follow-
ing equation:
F1370(t) = Eb,Ca*DCa(t) + Eb,Mg*DMg(t) + eEfD(t), (7)
where Eb,a and Eb,Mg are the fluorescence coefficients for
the Ca2+ - and Mg2+-bound forms offuraptra during illu-
mination with 370 nm light, respectively (see Fig. 1).
The predicted fluorescence transients calculated in this
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manner are shown in Fig. 6 F (solid lines). As expected
from Fig. 6 E, the magnitude of the transient is de-
creased with higher basal [Mg"]. Expressed as AfDca
(not shown), the magnitude of the predicted fluores-
cence transients is 3.60% with 0.5 mM [Mg"] and
2.63% with 2.0 mM [Mg2>] . To examine whether
changes in [Mg2+] have a significant effect on the fluores-
cence transient, we repeated simulations in which
[ Mg2>] was held constant (dashed lines in Fig. 6 F). The
peak change in fluorescence predicted when [Mg2+] was
held constant is very similar to that predicted when
[ Mg>2+] was allowed to vary, as in Fig. 6 D. These simula-
tions point out that a) only after [Ca>2] has returned
near basal levels would the [Mg2 ] transient have a signif-
icant effect on the fluorescence transient, and b) changes
in furaptra fluorescence at the peak of the transient ap-
pear to be due overwhelmingly to changes in [Ca>2] with
little interference from the [Mg2+] transient.
DISCUSSION
Use of furaptra as a Mg2+ indicator
Furaptra was originally synthesized for use as an indica-
tor of [Mg2+ ]i ( 12). Clearly, the results of Konishi et al.
(11 ) and those of the present paper demonstrate that
furaptra is also a useful indicator for monitoring changes
in [Ca2+]i in skeletal and cardiac muscle. This raises the
general issue ofhow to interpret changes in furaptra fluo-
rescence. The selectivity of furaptra for Ca2+ over Mg2>
appears to be temperature dependent (27-fold at 37°C,
Raju et al. ( 12); 75-fold at room temperature, present
report; 120-fold at 16°C, Konishi et al. ( 11)) due to an
inverse relation between temperature and the affinity for
Mg . Thus, at lower temperatures, furaptra becomes a
progressively better Ca2+ indicator because changes in
[Mg2+ ]i produce a smaller change in fluorescence. In
skeletal (34) and cardiac muscle, the kinetics and the
waveform for changes in [Ca2+]i and [Mg2+]i during a
stimulated [Ca2+]i transient also appear to be different,
so that changes in fluorescence arising from changes in
[Ca2+]i and [Mg2+]i can be easily distinguished. In cells
where [Ca2+]i and [Mg2+]i tend to change slowly, partic-
ularly at higher temperatures, it may become difficult to
clearly identify changes in fluorescence with a change in
concentration of either cation.
Use of furaptra as a Ca2+ indicator
To use furaptra as a Ca2+ indicator, it was necessary to
establish that changes in [Ca2+]i could be measured reli-
ably without contamination by movement artifact and
changes in [Mg2+ ]i. Cleeman and Morad ( 13) have pre-
sented preliminary data that furaptra could be used as a
Ca2+ indicator in cardiac myocytes; however, [Ca2+ ]i
dependent changes in fluorescence could be identified in
only 5 of 15 cells examined. Such a low success rate
would call into question the reliability of measurements
made with furaptra. In this study, we did not have simi-
lar problems, as 91% of the cells loaded with furaptra
demonstrated [Ca> ]i-dependent fluorescence tran-
sients. The apparent improvement may reflect our at-
tempt to maximize the signal-to-noise ratio ofthe fluores-
cent signals by signal averaging records and by recording
fluorescence from the entire cell. In addition, we found
that three experimental maneuvers (increased depolar-
ization duration, increased pipette [ Na+ ], and exposure
to isoproterenol) all led to increases in the size of the
fluorescence transient consistent with expected increases
in the size of the [Ca> ]i transient. Thus, our results
show that furaptra can be a reliable indicator for stimu-
lated [Ca> ]i transients.
Movement artifacts were a problem in the data re-
ported by Cleeman and Morad (13). In the present
study, movement artifacts as large or larger than the cat-
ion-dependent changes in the raw fluorescence signal
were removed or minimized by multiplying the raw fluo-
rescence signal recorded during 370 nm illumination by
the relative change in fluorescence recorded during 350
nm illumination, close to the isosbestic point. Nonethe-
less, even in the raw fluorescence signal, movement arti-
facts did not completely obscure the Ca> -dependent
changes in fluorescence because the peak of the [Ca">]i
transient was reached before cell movement became
large. The other possible complication, that changes in
[Mg>]i concentration would significantly change the
amplitude ofthe furaptra fluorescence transient, also did
not appear likely (see below). Thus, changes in [Ca> ]i
at the peak of the transient could be reliably measured
and calibrated using furaptra as the Ca> indicator.
Only stimulated [Ca>]i transients were examined in
the present study. Such transients tend to be stereotyped
events (16) which are characterized by uniform in-
creases in [Ca>]i throughout the cell (35). However,
isolated rat myocytes are particularly prone to the ap-
pearance of spontaneous oscillations of cell length (36)
and [Ca">]i ( 16). If such spontaneous oscillations were
present, the myocytes were excluded from analysis be-
cause the stimulated [Ca>]i transients show marked
beat-to-beat variability ( 16), which precludes meaning-
ful signal averaging. We nonetheless attempted to cali-
brate the spontaneous oscillations in fluorescence that
were observed under such conditions by the single wave-
length calibration technique discussed in Berlin et al.
( 16); however, the low signal-to-noise ratio prevented
any useful calibration. A disadvantage of furaptra, there-
fore, is that its utility is limited to measuring changes in
[2Ca ]i under steady-state conditions where the [Ca2+
transient remains a stereotyped event.
Changes in [Mg 2 + ]i during the[Ca21 ]i transient
Lacking a means to experimentally examine changes in
[Mg> ]i during the [Ca>+]i transient, we developed a
computer simulation to predict how changes in [Mg> ]i
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could affect the fluorescence recorded with furaptra. The
concentrations of Mg2" and Ca2" buffers were taken
from literature values (33). These values seem reason-
able in light ofthe report ofSipido and Wier (37), whose
data suggested that the intrinsic Ca2" buffering capacity
of a cardiac myocyte is close to the value published in
Fabiato (33). Thus, the concentrations of the buffers
used in the present simulations for Ca> /Mg " competi-
tion, particularly calmodulin and troponin, may not be
greatly different from the cellular concentration.
The concentration of furaptra was assumed to be
equal to the electrode concentration. This value may ac-
tually be a lower-end estimate, inasmuch as fluorescence
measurements were taken when dye loading was near
equilibrium. Approximately 50% of cellular furaptra ap-
pears to be bound to intracellular macromolecules in
skeletal muscle fibers (3). Cellular binding has a relative
concentrating effect on fura-2 (14) and indo-1 in myo-
cytes (5). Thus, at equilibrium, cellular furaptra concen-
tration may exceed the electrode concentration.
An important assumption of the model is that total
myoplasmic Mg2> remains constant throughout the
[Ca2+]i transient. This assumption could be invalid if
large amounts of Mg2+ move into and out of the sarco-
plasmic reticulum and the mitochondria or across the
sarcolemma. Hogue and Hansford (38) showed that
millimolar changes in extramitochondrial [Mg2+] did
not significantly alter matrix [Mg2+] in mitochondria
isolated from rat heart. Thus, Mg2+ flux across the mito-
chondrial membrane is probably not an important con-
sideration in the model calculations. The ability ofMg2+
to move across the sarcoplasmic reticulum membrane
was examined by Somlyo et al. (39). These authors dem-
onstrated that sarcoplasmic reticulum Mg> content in-
creased with prolonged tetanic stimuli in skeletal mus-
cle. The amount of Mg2+ that would move across the
reticular membrane in response to a single stimulation is
probably much smaller. Even so, in terms of the model,
any Mg2+ movement into the sarcoplasmic reticulum
would decrease the total myoplasmic Mg2+ and, there-
fore, decrease the free Mg2+ transient. Finally, there are
Mg>2 transport mechanisms in the cardiac sarcolemma
that appear to change [Mg2+]i only very slowly (re-
viewed by Murphy [40]). These considerations lead us
to conclude that, over the time course of our simula-
tions, the assumption of constant total myoplasmic
Mg2+ would not lead to an underestimate of changes
in [Mg2+]i.
The simulations predict that the [Mg2+ ]i transient fol-
lowing a 2.0 ,gM [Ca2+]i transient will be 14-26 ,uM (ba-
sal [Mg2+]i 0.5-2.0 mM) and reach peak amplitude -1
s after the beginning of the [Ca>2 ]i transient. Kirschen-
lohr et al. (41) have attempted to measure changes in
[Mg2+ ]i during the cardiac cycle with gated '9F-NMR to
examine Mg2+ binding to (+)-fluorocitrate. These au-
thors could find no significant change in [Mg2+]i with
ferret hearts paced at 1.25 Hz. The lack ofany change in
[Mg> ]i could reflect the short cycle length for pacing;
however, it could also represent a methodological prob-
lem. The probe was loaded as the acetoxy methyl ester,
and this method ofloading often results in a sizable frac-
tion ofthe probe residing in the mitochondria which, as
discussed above, is not likely to have a [Mg">]i transient.
Thus, the results of Kirschenlohr et al. (41) should be
interpreted as ruling out very large changes in [Mg> ]i
during the transient. Our model calculations also suggest
that large changes in [Mg> ]i are unlikely.
Changes in [Mg>]i following [Ca>]i transients in
skeletal muscle have been examined by determining
non-Ca2 -dependent changes in antipyrylazo III absor-
bance (34, 42). These authors report that [Mg2+], in-
creases -60 AM in response to a single stimulus. A com-
parison with cardiac muscle is difficult because the in-
crease in [Mg2]I, in skeletal muscle appears to occur
largely because Ca>2 displaces Mg2> from parvalbumin
(34), a protein that appears to be almost absent in rat
cardiac cells (43). Nonetheless, the amount of Ca21 in-
volved in a skeletal muscle [Ca2+]i transient (44) is sev-
eral times that in a cardiac muscle [Ca>2], transient (9,
45), so that the [ Mg2> ]i transient in skeletal muscle prob-
ably represents an upper-end estimate for that in cardiac
muscle.
The present model for [Mg2>]i in cardiac cells does
demonstrate that slow buffer species, particularly tro-
ponin, dominate the change in [Mg21 ], in response to a[Ca2"]i transient. This occurs because a significant frac-
tion of fast, low-affinity buffer species exist in metal-free
form, whereas the high-affinity, slow buffers are almost
completely Mg>2 or Ca> bound. An increase in [Ca2 ]i,
therefore, leads to displacement of Mg2> from the slow
buffers with consequent Mg>2 binding to fast buffer spe-
cies, quite similar to the case in skeletal muscle. In terms
of affecting the furaptra fluorescence transient, the slow
changes in [Mg2+]i mean that the peak of the fluores-
cence transient will not be significantly altered by
changes in [Mg>2 ]j. Fig. 6 F also predicts, however, that
changes in [Mg> ]i could affect the later phases of the
transient when [Ca2+ ]i has returned to near basal levels.
Comparison of [Ca2+ ]i transients
determined with furaptra and other
indicators
Several indicators are now available to measure the
[Ca2+]i in the heart, including aequorin, the ratiometric
fluorescent indicators such as fura-2 and indo- 1, 19F-
BAPTA for gated nuclear magnetic resonance (NMR),
and nonratiometric indicators such as fluo-3 and cal-
cium-X (Crimson, Green, et cetera). Despite the fact
that the experimental conditions under which these dif-
ferent indicators have been used are quite varied and
that the assumptions involved in calibration are differ-
ent, it is interesting to compare the [Ca2+]i transients
reported by some ofthe more commonly used indicators
with those reported by furaptra.
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As shown in Figs. 2 and 3, one advantage of furaptra is
that calibration in terms of [Ca2 ]i is relatively straight-
forward. The binding stoichiometry is 1:1 and, in the
range of [Ca2 ]i encountered in the present study, only a
small fraction of the total indicator binds with Ca>.
Thus, changes in fluorescence during 370 nm illumina-
tion are linear with spatial mean [Ca2 ]i (Fig. 3). In the
presence of rapid changes of [Ca2 ]i during the tran-
sient, furaptra will also accurately report [Ca2 ]i because
of the indicator's low Ca>2 affinity. In regards to this
point, experiments in skeletal muscle fibers have shown
that the time course of the furaptra fluorescence tran-
sient is much faster than that for high-affinity indicators
such as fura-2 ( 1). These advantages of furaptra, how-
ever, must be weighed against the disadvantage of the
low signal-to-noise ratio and the Mg2> sensitivity of this
indicator.
Eq. 4 also shows that a source of error in the calibra-
tion procedure is the determination ofKD. For the pres-
ent experiments, KD was determined in vitro and then
corrected for Mg2> competition. It is unlikely, however,
that this accurately reflects the affinity of furaptra for
Ca>2 in the cell. Furaptra is reported to be 50% bound in
skeletal muscle ( 1 1), and binding to proteins appears to
decrease the Ca>2 affinity of furaptra severalfold (Mapp,
A. K., and J. R. Berlin, unpublished observations), simi-
lar to the effect of protein binding on fura-2 (3) and
indo- 1 ( 5 ). Thus, assuming furaptra also binds to intra-
cellular constituents in cardiac myocytes, the reported
changes in [Ca>2]i should be considered lower-end esti-
mates of the true change in [Ca2+]i.
[Ca>2]i transients in electrically stimulated ventricu-
lar muscle preparations measured with aequorin have
generally been reported to be 1-2 AM in amplitude
under a wide variety of experimental conditions ( 1, 9),
similar to the size ofthe transient reported with furaptra.
Generally, two problems are recognized with aequorin
estimates of [Ca2 ]i. First, like furaptra, Mg2+ has im-
portant effects on Ca2+-dependent luminescence. Many
previous calibrations ofaequorin luminescence assumed
[Mg2+ ]i to be 2-3 mM, whereas recent estimates suggest
that the value is closer to 0.5-1.0 mM (40). Mg2+ in-
hibits the Ca2+ reaction with aequorin (46) in such a way
that, with [Ca2+] below 3 AM, decreased estimates of
[Mg2>]i would simply scale down the size of the tran-
sient. The magnitude of the resulting overestimation of
[Ca2+]j, however, could be as large as 50-75% (47). The
more widely appreciated problem with aequorin is due
to the steep dependence of luminescence on [Ca>2]
(46). In the presence of spatial gradients of [Ca2+]i,
which are likely to be present during rapid release of
Ca>2 from the sarcoplasmic reticulum (8, 9), aequorin
will overestimate [Ca2 ]i. Wier and Yue (9) carried out
simulations using a 1-MM [Ca2+] transient and found
that the magnitude ofthis overestimation to be 7%. How-
ever, with transients as large as those reported by furap-
tra, more pronounced spatial gradients of [Ca> ]i may
exist so that the true overestimation of [Ca> ]i may be
much greater. Consideration of inaccurate estimates of
[Mg> ]i and the steep [Ca>]i dependence of lumines-
cence suggest that many previous estimates of [Ca> ]i
with aequorin could produce an overestimate of size of
the [Ca>]i transient. Thus, the [Ca2+]i transient re-
ported by furaptra represents a change in [Ca2+]i that is
as large or larger than that reported by aequorin.
In contrast with aequorin, Ca2+ indicators such as
indo- 1, fura-2, and '9F-BAPTA tend to underestimate
the true size of the [Ca2+]i transient. These indicators
bind Ca2+ with 1:1 stoichiometry and have in vitro disso-
ciation constants of 100-300 nM (2). Thus, one disad-
vantage ofthese indicators is that, during rapid release of
sarcoplasmic reticulum Ca>, spatial gradients of
[Ca2+]i are likely to exist (8, 9), which could lead to
significant saturation of the indicator and underestima-
tion of spatial mean [Ca 2+ ]( 10). If the affinity of these
indicators for Ca2+ in the cell is decreased (3, 5), dye
saturation may be less severe than anticipated. Nonethe-
less, calibrations that use the KD determined in vitro are
still likely to underestimate [Ca2+]i.
Given the above reservations, we can compare the size
of [Ca2+]i transients reported with furaptra and '9F-
BAPTA or fura-2. Kusuoka et al. (48) used gated NMR
with '9F-BAPTA-loaded ferret hearts stimulated at 0.8-
1.4 Hz to determine that the average change in [Ca2+]i
near the peak ofthe transient was 430 and 780 nM (con-
trol and postischemia, respectively). The advantage of
this technique is that the relative amount of bound and
free '9F-BAPTA can be determined directly from the
area under the peaks of the NMR spectra. By compari-
son, calibration of fura-2 and indo- also requires the
determination of the fluorescence ratios in Ca2+-free
(Rmin) and saturating Ca2+ conditions (Rmax). The work
of Li et al. (49) suggests that Rmin and Rmax in myocytes
may be different than under in vitro conditions. Nonethe-
less, using in vitro calibration techniques, the amplitude
of the [Ca]2+] transient determined with fura-2 is only
one fourth as large as the transient determined with fur-
aptra under the same conditions ( 14). The reasons for
this apparent discrepancy need to be examined more
thoroughly before it is possible to conclude that fura-2
and furaptra report different [Ca2+]i.
Several nonratiometric fluorescent Ca>2 indicators
such as fluo-3 and the calcium-X analogues have also
been introduced. Some of these indicators have the ad-
vantage of Ca>2 affinities intermediate to those of fura-2
and furaptra but with extremely low affinities for Mg2+.
The inability to correct for movement artifacts, however,
will limit the utility of these indicators and may explain
why they have not been used extensively to quantitate
changes in [Ca2+]i during cell contraction.
In summary, several Ca2+ indicators are available to
measure [Ca2+]i in cardiac myocytes, each with its own
advantages and disadvantages. Furaptra, with the lowest
Ca2+ affinity, is useful for large and rapid [Ca2+]i tran-
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sients that are stereotyped events. Fura-2 and indo- 1 are
particularly useful for smaller changes in [Ca2], that
may not be reproducible. Uncertainties remain in the
calibration procedures for these indicators. However,
given the relative simplicity ofthe calibration procedure
used for furaptra, the size of the [Ca2]i transient re-
ported in the present study should be considered at least
as accurate as other methods. Thus, the size of the
[Ca2]i transient determined with furaptra is as large or
larger than that determined with other Ca>2 indicators.
Furthermore, measurements of peak changes in [Ca2]i
with furaptra appear to be reliable and without signifi-
cant interference from Mg2+.
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